XYRA Receives US Patent To Lower Heart Failure And Stroke Risk
04 Mar 2026 //
PR NEWSWIRE
XYRA Secures Fifth US Patent for Budiodarone in AF Management
24 Apr 2025 //
PR NEWSWIRE
XYRA Announces FDA Guidance For Atrial Fibrillation Management
16 Oct 2024 //
PR NEWSWIRE

Market Place
Sourcing Support